Abstract | BACKGROUND:
Transplantation has become a lifesaving procedure for children with end-stage heart failure. The long-term outcome for children who undergo transplantation has been of considerable interest, but the causes of graft failure and death are largely unknown, and the role of pre-transplant viral infection is unclear. METHODS: RESULTS: We identified parvoviral genomes in 6 patients (3 with CHD and 3 with cardiomyopathy). We detected no other viruses. Immunohistochemistry showed normal staining for key components of the cytoskeleton/sarcolemma, sarcomere, and nuclear membrane in the 6 virus-positive samples. The clinical outcome of these children was worse (4 long-term survivors, but 2 deaths) than for individuals without the genome. CONCLUSIONS: Detecting viruses within the myocardium at the point of end-stage heart failure is not common, regardless of the primary pathology. However, the presence of viruses may result in poor outcome for the patient.
|
Authors | Paola Francalanci, Jamie L Chance, Matteo Vatta, Shinawe Jimenez, Hua Li, Jeffrey A Towbin, Neil E Bowles |
Journal | The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
(J Heart Lung Transplant)
Vol. 23
Issue 9
Pg. 1046-52
(Sep 2004)
ISSN: 1053-2498 [Print] United States |
PMID | 15454170
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Topics |
- Child
- Female
- Heart
(virology)
- Heart Defects, Congenital
(virology)
- Heart Diseases
(virology)
- Heart Transplantation
- Humans
- Immunohistochemistry
- Male
- Parvoviridae Infections
(diagnosis)
- Reverse Transcriptase Polymerase Chain Reaction
- Sequence Analysis, DNA
- Virus Diseases
(diagnosis)
|